Excercise and lymphocyte activation following chemotherapy for breast cancer

Medicine and Science in Sports and Exercise

Volumn 37, Issue 11, 2005, Pages 1827-1835

  Hutnick, Natalie A ^a   Williams, Nancy I ^a   Kraemer, William J ^b   Orsega Smith, Elizabeth ^c   Dixon, Richard H ^d   Bleznak, Aaron D ^e   Mastro, Andrea M ^a,f  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d Centre Medical and Surgical Associates   (United States)

^e LEHIGH VALLEY HOSPITAL   (United States)

^f Lehigh Valley Hospital ^*  (United States)

Author keywords

Interferon gamma; Interleukin 6; Mitogen; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD69 ANTIGEN; CONCANAVALIN A; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 6; METHOTREXATE; PACLITAXEL; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HELPER CELL; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; BREAST TUMOR; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL TRIAL; COMPARATIVE STUDY; FITNESS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KINESIOTHERAPY; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; EXERCISE THERAPY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PHYSICAL FITNESS;

EID: 28044452832     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000175857.84936.1a     Document Type: Article

References (26)

1. Deleted in proof.
2. BARAK, V., I. KALICKMAN, B. NISMAN, et al. Changes in cytokine production of breast cancer patients treated with interferons. Cytokine 10:977-983, 1998.
3. DIMEO, F., S. FETSCHER, W. LANGE, R. MERTELSMANN, and J. KEUL. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 90:3390-3394, 1997.
4. ESKOLA, J., O., RUUSKANEN, E., SOPPI, et al. Effect of sport stress on lymphocyte transformation and antibody formation. Clin. Exp. Immunol. 32:339-345, 1978.
5. FAIREY, A. S., COURNEYA, K. S. FIELD, C. J. BELL, G. J. JONES, and L. W. MACKEY. J. R. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J. Appl. Physiol. 98:1534-1540, 2005.
6. HAKIM, F. T., R. CEPEDA, S. KAIMEI, et al. Constraints on CD4 recovery post chemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-3798, 1997.
7. HANNET, I., F. ERKELLER-YUKSEL, P. LYDYARD, V. DENEYS, and M. DEBRUYERE. Developmental and maturational changes in human blood lymphocyte populations. Immunol. Today 13:215-218, 1992.
8. HAYES, S. C., D. ROWBOTTOM, P. S. W. DAVIES, T. W. PARKER, and J. BASHFORD. Immunological changes after cancer treatment and participation in an exercise program. Med. Sci. Sports Exerc. 35:2-9, 2003.
9. JIANG, X. P., D. C. YANG, R. L. ELLIOT, and J. F. HEAD. Reduction in serum IL-6 After vaccination of breast cancer patients with tumor-associated antigens is related to estrogen receptor status. Cytokine 12:458-465, 2000.
10. JOSTOCK, T., J. MULLENBERG, S. OZBEK, R. ATREYA, G. BLINN, and N. VOLTZ. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268:160-167, 2001.
11. KIDD, P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8:223-246, 2003.
12. KRAEMER, W. J., and A. C. FRY. Strength testing: development and evaluation of methodology. In: Physiological Assessment of Human Fitness, P. Maud and C. Fost (Eds.). Champaign, IL: Human Kinetics Pub. Inc., 1995:115-138.
13. KRAEMER, W. J., J. PATTON, S. E. GORDON, et al. Compatibility of high intensity strength and endurance training on hormonal and skeletal muscle adaptations. J. Appl. Physiol. 78:976-989, 1995.
14. LAPERRIERE, A., N. KILMAS, M. A. FLETCHER, et al. Change in CD4 cell enumeration following aerobic exercise training in HIV-1 disease: possible mechanisms and practical applications. Int. J. Sports Med. 18:556-561, 1997.
15. LAPPIN, M. B., and J. D. M. CAMPBELL. The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in hematological malignancy. Blood Rev. 14:228-239, 2000.
16. NARAZAKI, M., K. YASUKWA, T. SAITO, et al. Soluble forms of the interleukin-6 signal transducing receptor component gp130 in human serum possessing a potential to inhibit signals through a membrane anchored gp130. Blood 82:1120-1126, 1993.
17. NINDL, B. C., E. A. HARMAN, J. O. MARX, et al. Regional body composition changes in women after 6 months of periodized physical training. J. Appl. Physiol. 88:2251-2259, 2000.
18. PERNA, F. M., A. LAPERRIERE, N. KLIMAS, et al. Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med. Sci. Sports Exerc. 31:973-979, 1997.
19. PETERS, M., S. JACOBS, M. EHLERS, et al. The function of the soluble interleukin-6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399-1406, 1996.
20. PIGNATTI, P., L. CIAPPONI, P. GALLE, et al. High circulating levels of biologically inactive IL-6/sIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130. Clin. Exp. Immunol. 131:355-363, 2003.
21. POLLOCK, M. L., G. A. GAESSER, J. D. BUTCHER, et al. ACSM position stand: the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med. Sci. Sports Exerc. 30:975-991, 1998.
22. SALKELD, B. D., J. C. MACAULAY, R. W. BALL, and J. G. CANNON. Modulation of body temperature, interleukin-6 and leptin by oral contraceptive use. Neuroimmunomodulation 9:319-325, 2001.
23. SEGAL, R., W. EVAN, D. JOHNSON, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J. Clin. Oncol. 19:657-665, 2001.
24. TIDBALL, J. G. Interactions between muscle and the immune system during modified musculoskeletal loading. Clin. Orthop. Relat. Res. (403 Suppl)S100-109, 2002,
25. WENDELBO, O., I. NESTHUS, M. SJO, K. PAULSEN, P. ERNST, and O. BRUSERUD. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leucopenia. Cancer Immunol. Immunother. 53:740-747, 2004.
26. YAMASHTTA, J., T. HIDESHIMA, T. SHIRAKUSA, and M. OGAWA. Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma. Cancer 78:2346-2352, 1996.